138 related articles for article (PubMed ID: 2770890)
1. Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.
Ask AL; Fagervall I; Huang RB; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):684-9. PubMed ID: 2770890
[TBL] [Abstract][Full Text] [Related]
2. Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effects.
Rényi L; Ross SB
Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):416-26. PubMed ID: 4036634
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
Ask AL; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):591-6. PubMed ID: 2965308
[TBL] [Abstract][Full Text] [Related]
4. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
Rényi L
Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.
Ask AL; Fagervall I; Jonze M; Kelder D; Nygren R; Ross SB
Biochem Pharmacol; 1984 Sep; 33(18):2839-47. PubMed ID: 6477643
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
Ask AL
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):56-63. PubMed ID: 6493351
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.
Ask AL; Fagervall I; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):79-87. PubMed ID: 6646243
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoamine oxidase A-form and semicarbazide-sensitive amine oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+).
Morikawa F; Ueda T; Arai Y; Kinemuchi H
Pharmacology; 1986; 32(1):38-45. PubMed ID: 3945672
[TBL] [Abstract][Full Text] [Related]
9. Failure to detect any transport of the irreversible monoamine oxidase inhibitor N-cyclopropyl-4-chloroamphetamine by the carrier of 5-hydroxytryptamine in the brain of the rat in vivo.
Fagervall I; Ross SB
Neuropharmacology; 1986 Aug; 25(8):911-3. PubMed ID: 3490629
[TBL] [Abstract][Full Text] [Related]
10. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.
Archer T; Fowler CJ; Fredriksson A; Lewander T; Magnusson O; Mohringe B; Söderberg U
Br J Pharmacol; 1985 Jul; 85(3):581-90. PubMed ID: 2411326
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase in 5-hydroxytryptaminergic neurones by substituted p-aminophenylalkylamines.
Ask AL; Fagervall I; Florvall L; Ross SB; Ytterborn S
Br J Pharmacol; 1985 Jul; 85(3):683-90. PubMed ID: 3861206
[TBL] [Abstract][Full Text] [Related]
12. Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: electrophysiological studies in the rat CNS.
Blier P; de Montigny C; Azzaro AJ
Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):253-60. PubMed ID: 3808082
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).
Fowler CJ; Eriksson M; Thorell G; Magnusson O
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):279-84. PubMed ID: 6514012
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat.
Ask AL; Hellström W; Norrman S; Ogren SO; Ross SB
Neuropharmacology; 1982 Apr; 21(4):299-308. PubMed ID: 7088264
[TBL] [Abstract][Full Text] [Related]
15. (+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.
Ask AL; Högberg K; Schmidt L; Kiessling H; Ross SB
Biochem Pharmacol; 1982 Apr; 31(7):1401-6. PubMed ID: 7092929
[TBL] [Abstract][Full Text] [Related]
16. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.
Blier P; Bouchard C
Br J Pharmacol; 1994 Oct; 113(2):485-95. PubMed ID: 7834200
[TBL] [Abstract][Full Text] [Related]
17. The mechanism by which monoamine oxidase inhibitors give rise to a non-calcium-dependent component in the depolarization-induced release of 5-HT from rat brain synaptosomes.
Evans SM; Collard KJ
Br J Pharmacol; 1988 Nov; 95(3):950-6. PubMed ID: 3264736
[TBL] [Abstract][Full Text] [Related]
18. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Crespi D; Mennini T; Gobbi M
Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones.
Ask AL; Fagervall I; Florvall L; Ross SB; Ytterborn S
Neuropharmacology; 1986 Jan; 25(1):33-40. PubMed ID: 3005903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
